热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD150 (SLAM) Antibody
产品名称：
PE/Cyanine7 anti-mouse CD150 (SLAM) Antibody
产品类别：
抗体
产品编号：
115913
产品应用：
115913
[价格]
规格 价格 库存
25µg ￥ 1568 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse SLAM-human IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD150 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The TC15-12F12.2 antibody has been reported to enhance the production of IFN-? by Th1 cells stimulated through TCR. Additional reported applications (for the relevant formats) include: immunoprecipitaion17, enhancing IFN-? production by Th1 cells when stimulated with CD31, and inhibiting CD3 induced T cell proliferation6. The Ultra-LEAF? purified antibody (Endotoxin <0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 115949 & 115950).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Castro AG, et al. 1999. J. Immunol. 163:5860. (FC, Costim, IP)
  2. Forsberg EC, et al. 2005. PLoS Genet. 1:e28. (FC)
  3. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (FC)
  4. Cannons JL, et al. 2006. J. Exp. Med. 203:1551. (FC)
  5. Umemoto T, et al. 2006. J. Immunol. 177:7733. (FC)
  6. Jordan MA, et al. 2007. J. Immunol. 178:1618. (FC, Block) PubMed
  7. Jung Y, et al. 2007. Blood 110:82. PubMed
  8. Pimanda JE, et al. 2007. Proc. Natl. Acad. Sci. USA 104:840.
  9. Sugiyama T, et al. 2007. Proc. Natl. Acad. Sci. USA 104:175.
  10. Kim I, et al. 2006. Blood 108:737. PubMed
  11. Ema H, et al. 2006. Nat Protoc. 1:2979. PubMed
  12. Fraser ST, et al. 2007. Blood 109:4616. PubMed
  13. Jung Y, et al. 2008. Stem Cells. 26:2042. Pubmed
  14. Song J, et al. 2010. Blood 115:2592. PubMed
  15. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 43:149. (FC) PubMed
  16. Morita Y, et al. 2010. J. Exp Med. 207:1173. PubMed
  17. Talaei N, et al. 2015. J. Immunol. 195(10):4623. PubMed
Product Citations
  1. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  2. Upadhaya S, et al. 2020. Cell Stem Cell. 27(2):336-345.e4. PubMed
  3. Luchsinger LL, et al. 2020. Cell Stem Cell. 25(2):225-240. PubMed
  4. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  5. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  6. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  7. Muto T, et al. 2020. Nat Immunol. 1.246527778. PubMed
  8. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  9. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  10. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  11. Grinenko T, et al. 2018. Nat Commun. 9:1898. PubMed
  12. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  13. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  14. Paubelle E, et al. 2020. Cell Reports. 30(3):739-754.e4.. PubMed
  15. Sykes DB et al. 2016. Cell. 167(1):171-186 . PubMed
  16. Bonnet C, et al. 2021. iScience. 24:103399. PubMed
  17. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  18. Wilkinson AC, et al. 2020. Nature Protocols. 15(2):628-648.. PubMed
  19. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  20. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  21. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  22. Jordan M, et al. 2011. J Immunol. 186:3953. PubMed
  23. Eisele AS, et al. 2022. Elife. 11:. PubMed
  24. Gustafsson K, et al. 2013. Exp Cell Res. 319:1852. PubMed
  25. Halene S, et al. 2010. Blood. 116:1942. PubMed
  26. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  27. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  28. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  29. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  30. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  31. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  32. de Almeida MJ et al. 2017. Cell stem cell. 21(6):725-729 . PubMed
  33. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  34. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  35. Yankova E, et al. 2021. Nature. 593:597. PubMed
  36. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  37. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  38. Passaro D et al. 2017. Cancer cell. 32(3):324-341 . PubMed
  39. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  40. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  41. Tober J, et al. 2013. Development. 140:3765. PubMed
  42. Yang T, et al. 2022. Nat Commun. 13:4464. PubMed
  43. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  44. Liang R, et al. 2020. Cell Stem Cell. 359:26. PubMed
  45. Yu W, et al. 2020. J Clin Invest. . PubMed
  46. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  47. Hormaechea-Agulla D, et al. 2021. Cell Stem Cell. . PubMed
  48. Karamitros D, et al. 2015. Development. 142:70. PubMed
  49. de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
  50. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  51. Florez MA, et al. 2020. Cell Rep. 33:108530. PubMed
  52. Xia P, et al. 2015. J Exp Med. 212: 2305 - 2321. PubMed
  53. Nestorowa S, et al. 2016. Blood. 128: e20 - e31. PubMed
  54. Tzelepis K, et al. 2018. Nat Commun. 9:5378. PubMed
  55. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  56. Glotzbach J, et al. 2011. PLoS One. 6:e21211. PubMed
  57. Young IC, et al. 2021. Cell Rep. 37:110036. PubMed
  58. Koide S, et al. 2022. iScience. 25:103603. PubMed
  59. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  60. Ueda K, et al. 2021. Cancer Cell. 39(4):529-547.e7. PubMed
  61. Chlon TM, et al. 2021. Cell Stem Cell. :. PubMed
  62. Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
  63. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  64. Kent D, et al. 2009. Blood. 113:6342. PubMed
  65. Wilkinson AC, et al. 2019. Nature. 571:117. PubMed
  66. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  67. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  68. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  69. Guo F, et al. 2013. Haematologica. 98:1353. PubMed
  70. Gozdecka M, et al. 2018. Nat Genet. 50:883. PubMed
  71. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  72. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  73. Fast EM, et al. 2021. Elife. 10:. PubMed
  74. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  75. Rimmelé P, et al. 2015. EMBO Rep. 16: 1164-1176. PubMed
  76. Gerhardt D, et al. 2014. Genes Dev. 28:576. PubMed
RRID
AB_439796 (BioLegend Cat. No. 115913) AB_439797 (BioLegend Cat. No. 115914)

Antigen Details

Structure
Ig superfamily, 75-95 kD
Distribution

Thymocytes, T cell subset, B lymphocytes, dendritic cells, endothelial cells

Function
B cell and dendritic cell costimulation
Ligand/Receptor
CD150
Cell Type
B cells, Dendritic cells, Endothelial cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Cocks BG, et al. 1995. Nature 376:260.
2. Punnonen J, et al. 1997. J. Exp. Med. 185:993.
3. Sidorenko SP, et al. 1993. J. Immunol. 151:4614.

Gene ID
27218 View all products for this Gene ID
UniProt
View information about CD150 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线